Xiao Wei resigns as Chairman of Kanion Pharmaceutical, stepping back to "cultivate successors"
Kanion Pharmaceutical announced today that Xiao Wei has resigned as the chairman of the company. Company insiders told reporters: "Due to age reasons, he will focus on the company's strategy and research and development in the future, as well as on cultivating successors." Regarding the chairman's resignation, company insiders emphasized to reporters that there are no other special reasons, "he has only resigned from the position of chairman, and he will still serve as a director of the company and will participate in some of the company's operational management work."
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments